Beyond the Injections: Why Psychology Still Matters with GLP-1 Weight Loss Treatments

Author: Dr Hannah Osborne, Consultant Clinical Psychologist and EMDR UK Accreditated practitioner providing therapy & EMDR in Berkhamsted, Tring & Hertfordshire

GLP-1 medications have changed the conversation around weight.

Drugs such as Semaglutide (marketed as Wegovy and Ozempic) and Tirzepatide (Mounjaro) work by mimicking hormones involved in appetite and satiety. For many people, they significantly reduce hunger, cravings and what is often described as “food noise.”

For some, this feels transformative.

But even with medical support, psychology still matters.

As a Clinical Psychologist providing therapy in Berkhamsted, Tring and across Hertfordshire, I often meet people who are losing weight — yet still feeling stuck emotionally.

Because weight is never just about appetite.

Appetite Is Biological. Eating Is Psychological.

GLP-1 medications influence biological hunger signals. They can reduce appetite, increase fullness and support meaningful weight reduction.

But eating patterns are also shaped by:

• Emotional regulation
• Stress and trauma history
• Habit learning
• Body image and self-worth
• Shame and internalised weight stigma
• Early experiences around food

Medication can quiet the body.
It does not automatically untangle the psychology.

I often hear:

“I’m not as hungry, but I still eat when I’m stressed.”
“I’m losing weight — but I don't feel good about myself.”
“I’m scared of what happens if I stop the injections.”

This is where therapy becomes essential.

If you’re seeking therapy in Berkhamsted, Tring or Hertfordshire alongside GLP-1 treatment, integrating psychological work can make outcomes more sustainable and compassionate.

An ACT Perspective: Moving Beyond Control

Acceptance and Commitment Therapy (ACT) is grounded in behavioural science and focuses on building psychological flexibility — the ability to experience thoughts and feelings without being dominated by them, while taking meaningful action aligned with values.

With GLP-1 treatment, ACT work might include:

• Noticing urges without automatically reacting
• Reducing shame and self-criticism
• Clarifying values beyond weight or appearance
• Developing sustainable habits rooted in identity, not fear
• Stepping out of all-or-nothing dieting cycles

GLP-1 medication may reduce biological drive.
ACT helps change your relationship with food, body image and self-worth and that’s where deeper change happens.

An EMDR Perspective: When Weight Is Linked to Experience

Sometimes eating patterns are connected to earlier experiences:

• Bullying or body shaming
• Emotional neglect
• Trauma or chronic stress
• Medical experiences
• Repeated dieting cycles and perceived “failure”

Eye Movement Desensitization and Reprocessing (EMDR) helps process distressing memories so they no longer carry the same emotional charge.

As a psychologist offering EMDR in Berkhamsted, Tring and Hertfordshire, I often see how unresolved experiences can subtly drive present behaviours — even when appetite is medically reduced.

When those memories are processed, patterns often soften naturally.

It’s not about blaming the past.
It’s about freeing the present.

Why GLP-1 Psychological Support Matters

Without psychological support, people can struggle with:

• Fear of weight regain
• Body dissatisfaction despite weight loss
• Transfer of coping behaviours
• Identity confusion (“Who am I if I’m not dieting?”)
• Anxiety about stopping medication

Weight loss does not automatically equal emotional wellbeing.

If you’re receiving GLP-1 treatment and looking for GLP-1 psychological support in Berkhamsted, Tring or Hertfordshire, integrating therapy can help ensure the changes you’re making are sustainable, values-driven and emotionally grounded.

Medication can support your physiology.
Psychology supports your whole story.

Selected Research & Guidelines

1. Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384, 989–1002.
   – STEP 1 trial demonstrating significant weight reduction with semaglutide.

2. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387, 205–216.
   – SURMOUNT-1 trial showing substantial weight loss outcomes with tirzepatide.

3. NICE (National Institute for Health and Care Excellence). (2023). Semaglutide for managing overweight and obesity (TA875).
   – UK guidance on the clinical use of GLP-1 medications for obesity.

4. Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (2012). Acceptance and Commitment Therapy: The Process and Practice of Mindful Change. Guilford Press.
   – Foundational ACT text outlining psychological flexibility as a mechanism of change.

5. A-Tjak, J. G. L., et al. (2015). A meta-analysis of the efficacy of Acceptance and Commitment Therapy for clinically relevant mental and physical health problems. Psychotherapy and Psychosomatics, 84, 30–36.

6. Shapiro, F. (2018). Eye Movement Desensitization and Reprocessing (EMDR) Therapy: Basic Principles, Protocols, and Procedures. Guilford Press.

7. WHO (2013) & NICE (2018). Guidelines recommending EMDR as an evidence-based treatment for PTSD.

8. Forman, E. M., et al. (2013). Acceptance-based behavioral treatment for weight control: A review and future directions. Journal of Contextual Behavioral Science.
   – Evidence supporting ACT-based approaches in weight-related interventions.